These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Absence of lenadogene nolparvovec DNA in a brain tumor biopsy from a patient in the REVERSE clinical study, a case report. Newman NJ; Schniederjan M; Mendoza PR; Calkins DJ; Yu-Wai-Man P; Biousse V; Carelli V; Taiel M; Rugiero F; Singh P; Rogue A; Sahel JA; Ancian P BMC Neurol; 2022 Jul; 22(1):257. PubMed ID: 35820885 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for visual acuity in patients with Leber's hereditary optic neuropathy after rAAV2-ND4 gene therapy. Zhang Y; Li X; Yuan J; Tian Z; Liu H; Wang D; Li B Clin Exp Ophthalmol; 2019 Aug; 47(6):774-778. PubMed ID: 30968497 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy. Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279 [TBL] [Abstract][Full Text] [Related]
8. Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical Trial. Bouquet C; Vignal Clermont C; Galy A; Fitoussi S; Blouin L; Munk MR; Valero S; Meunier S; Katz B; Sahel JA; Thomasson N JAMA Ophthalmol; 2019 Apr; 137(4):399-406. PubMed ID: 30730541 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A Newman NJ; Yu-Wai-Man P; Carelli V; Biousse V; Moster ML; Vignal-Clermont C; Sergott RC; Klopstock T; Sadun AA; Girmens JF; La Morgia C; DeBusk AA; Jurkute N; Priglinger C; Karanjia R; Josse C; Salzmann J; Montestruc F; Roux M; Taiel M; Sahel JA Front Neurol; 2021; 12():662838. PubMed ID: 34108929 [No Abstract] [Full Text] [Related]
15. Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial. Lam BL; Feuer WJ; Schiffman JC; Porciatti V; Vandenbroucke R; Rosa PR; Gregori G; Guy J JAMA Ophthalmol; 2014 Apr; 132(4):428-36. PubMed ID: 24525545 [TBL] [Abstract][Full Text] [Related]
16. Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study. Vignal-Clermont C; Girmens JF; Audo I; Said SM; Errera MH; Plaine L; O'Shaughnessy D; Taiel M; Sahel JA BioDrugs; 2021 Mar; 35(2):201-214. PubMed ID: 33566264 [TBL] [Abstract][Full Text] [Related]
20. Visual Acuity Testing Before and After Intravitreal Injection of rAAV2-ND4 in Patients. Li B; Wu C Methods Mol Biol; 2018; 1715():305-311. PubMed ID: 29188523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]